Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected3M Return
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | AKRO | MRNA | PFE |
|---|---|---|---|
| Return | |||
| Last Price | 54.70 | 144.92 | 28.47 |
| Daily Change | — | − 2.65% | − 1.18% |
| Period ReturnPast 3 Months | — | + 217.64% | + 11.00% |
| Valuation | |||
| Market Cap | $4.50 B | $57.5 B | $162 B |
| P/E Ratio | — | — | 37.69 |
| Dividend Yield | — | — | 5.38% |
| Net MarginTrailing 12M | — | 141.4% | 6.8% |
| Risk | |||
| Beta | 0.90 | 1.22 | 0.28 |
| 52-Week Range | 41.77 — $54.83 | 22.28 — $176.66 | 23.58 — $29.21 |
| Company | |||
| Sector | — | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology | Pharmaceuticals |
Company
- AKROBiotechnology
- MRNAHealth Care · Biotechnology
- PFEHealth Care · Pharmaceuticals
Alpaca · SIPUpdated 00:0715 Minutes Delayed
To Understand This